Patents by Inventor Kong Yong Then

Kong Yong Then has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Cell-based composition and use thereof for treatment of diabetes and associated metabolic disorders and for amelioration of insulin resistance in pre-diabetes
    Patent number: 11052119
    Abstract: The present invention relates to a cell-based composition comprising a suspension of mesenchymal stem cells in crystalloid with a cellular concentration from 0.01 million to 3.0 million cells/ml. The cell-based composition is used in a form of medicament for treatment of diabetes and its associated metabolic disorders and complications.
    Type: Grant
    Filed: February 25, 2019
    Date of Patent: July 6, 2021
    Assignee: Cytopeutics Sdn. Bhd.
    Inventors: Bernard Sze-Piaw Chin, Kong Yong Then, Soon Keng Cheong
  • Cell-based composition and use thereof for treatment of vernal keratoconjunctivitis
    Patent number: 10828332
    Abstract: A method for the treatment of vernal keratoconjunctivitis in a subject by administering to said subject an effective amount of a cell-based composition containing a suspension of mesenchymal stem cells in crystalloid with a cellular concentration from 0.01 million to 3.0 million cells/ml.
    Type: Grant
    Filed: May 18, 2017
    Date of Patent: November 10, 2020
    Assignee: Cytopeutics Sdn. Bhd.
    Inventors: Bernard Sze Piaw Chin, Kong Yong Then, Soon Keng Cheong
  • CELL-BASED COMPOSITION AND USE THEREOF FOR TREATMENT OF DIABETES AND ASSOCIATED METABOLIC DISORDERS AND FOR AMELIORATION OF INSULIN RESISTANCE IN PRE-DIABETES
    Publication number: 20190209620
    Abstract: The present invention relates to a cell-based composition comprising a suspension of mesenchymal stem cells in crystalloid with a cellular concentration from 0.01 million to 3.0 million cells/ml. The cell-based composition is used in a form of medicament for treatment of diabetes and its associated metabolic disorders and complications.
    Type: Application
    Filed: February 25, 2019
    Publication date: July 11, 2019
    Inventors: Bernard Sze-Piaw Chin, Kong Yong Then, Soon Keng Cheong
  • Cell-based composition and use thereof for treatment of acute stroke
    Patent number: 10278993
    Abstract: A method for the treatment of acute stroke in a subject by administering to said subject an effective amount of a cell-based composition containing a suspension of mesenchymal stem cells in crystalloid with a cellular concentration from 0.01 million to 3.0 million cells/ml.
    Type: Grant
    Filed: May 17, 2017
    Date of Patent: May 7, 2019
    Assignee: Cytopeutics Sdn. Bhd.
    Inventors: Bernard Sze-Piaw Chin, Kong Yong Then, Soon Keng Cheong
  • CELL-BASED COMPOSITION AND USE THEREOF FOR TREATMENT OF PSORIASIS AND AUTOIMMUNE DISEASES
    Publication number: 20180028568
    Abstract: A method for the treatment of psoriasis or an autoimmune disease in a subject by administering to said subject an effective amount of a cell-based composition containing a suspension of mesenchymal stem cells in crystalloid with a cellular concentration from 0.01 million to 3.0 million cells/ml.
    Type: Application
    Filed: May 18, 2017
    Publication date: February 1, 2018
    Inventors: Bernard Sze Piaw Chin, Kong Yong Then, Soon Keng Cheong
  • CELL-BASED COMPOSITION AND USE THEREOF FOR TREATMENT OF VERNAL KERATOCONJUNCTIVITIS
    Publication number: 20170354685
    Abstract: A method for the treatment of vernal keratoconjunctivitis in a subject by administering to said subject an effective amount of a cell-based composition containing a suspension of mesenchymal stem cells in crystalloid with a cellular concentration from 0.01 million to 3.0 million cells/ml.
    Type: Application
    Filed: May 18, 2017
    Publication date: December 14, 2017
    Inventors: Bernard Sze Piaw Chin, Kong Yong Then, Soon Keng Cheong
  • CELL-BASED COMPOSITION AND USE THEREOF FOR TREATMENT OF MACULAR OEDEMA AND DEGENERATION
    Publication number: 20170354693
    Abstract: A method for the treatment of macular oedema and degeneration in a subject by administering to said subject an effective amount of a cell-based composition containing a suspension of mesenchymal stem cells in crystalloid with a cellular concentration from 0.01 million to 3.0 million cells/ml.
    Type: Application
    Filed: May 18, 2017
    Publication date: December 14, 2017
    Inventors: Bernard Sze Piaw Chin, Kong Yong Then, Soon Keng Cheong
  • CELL-BASED COMPOSITION AND USE THEREOF FOR TREATMENT OF ACUTE STROKE
    Publication number: 20170340675
    Abstract: A method for the treatment of acute stroke in a subject by administering to said subject an effective amount of a cell-based composition containing a suspension of mesenchymal stem cells in crystalloid with a cellular concentration from 0.01 million to 3.0 million cells/ml.
    Type: Application
    Filed: May 17, 2017
    Publication date: November 30, 2017
    Inventors: Bernard Sze Piaw Chin, Kong Yong Then, Soon Keng Cheong
  • CELL-BASED COMPOSITION AND USE THEREOF FOR TREATMENT OF DIABETES AND ASSOCIATED METABOLIC DISORDERS AND FOR AMELIORATION OF INSULIN RESISTANCE IN PRE-DIABETES
    Publication number: 20170340676
    Abstract: The present invention relates to a cell-based composition comprising a suspension of mesenchymal stem cells in crystalloid with a cellular concentration from 0.01 million to 3.0 million cells/ml. The cell-based composition is used in a form of medicament for treatment of diabetes and its associated metabolic disorders and complications.
    Type: Application
    Filed: May 17, 2017
    Publication date: November 30, 2017
    Inventors: Bernard Sze Piaw Chin, Kong Yong Then, Soon Keng Cheong